Aug 10, 2024

KaishunLaos
Type of disease: liver cancer
Treatment plan: interventional therapy + immunotherapy
Survival period: Survival is more than 5 years
Trusted Choice Health Trust

Kaishun
The first time I met Kaishun, a Laotian liver cancer patient, the time went back to five years ago. He was just diagnosed with liver cancer in 2019 and sought treatment all over the world. One moment, he refused the surgical recommendation of a local hospital in Thailand. The next moment, he underwent comprehensive minimally invasive treatment in our hospital. After the treatment, he was "healthy as usual", which made him very excited. Fast forward to 2023, more than three years ago. The epidemic period blocked the anti-cancer path, and due to the inability to conduct regular re-examinations, spread and metastasis occurred. As soon as the epidemic ended, he came to our hospital again for integrated minimally invasive treatment. What has changed over time, but what remains unchanged is the immediate therapeutic effect; in May 2024, this old friend came to our hospital again, mainly to enhance immunity. At this time, his physical condition was stable and he was in good spirits. For more than five years, at every stage, he entrusted his health to Guangzhou St. Stamford Hospital without hesitation.
Minimally invasive intervention is like new life
"Before the treatment, I was actually waiting to die, but after two minimally invasive interventional treatments, the original tumor shrank by 80%, and all physical indicators basically returned to normal." During the epidemic, he was unable to go abroad and had no treatment. Faced with the deterioration of his body, he was disheartened and waited silently for death. However, there is no end to the road. Just after the epidemic ended in 2023, Kaishun came to our hospital again. The original team of doctors were familiar with his condition and immediately formulated an effective treatment plan. Two minimally invasive interventions were performed in May and June 2023. Kaishun's condition was effectively controlled. Now after a review one year later, he is in good physical condition.

Director Kaishun and Ma Xiaoying
"I like to play golf. Many of my friends who got cancer chose radiotherapy and chemotherapy, and have never been seen on the golf course since. The vomiting, hair loss, weakness and some irreversible damage caused by systemic chemotherapy have never appeared on me, so the superiority of minimally invasive intervention is obvious." This is Kaishun's simplest description of the advantages of interventional therapy as a lung cancer patient. He may not be able to explain in professional medical terms that minimally invasive intervention uses non-intravenous injection, reaches the tumor directly, and does not damage normal cells, but he uses his most real experience to demonstrate how friendly minimally invasive intervention is to cancer patients. The biggest highlight of minimally invasive intervention is "minimally invasive" and "intervention". The incision is very small, and only a 1-2 mm incision is needed. Under the guidance of medical imaging equipment, such as CT, the drug is administered through puncture. The drug concentration is 2-92 times higher than that of systemic chemotherapy. It has the characteristics of no incision, less trauma, good effect, and rapid patient recovery.
When asked why he still chooses to come to our hospital for treatment after recurrence after the first treatment, Kaishun said frankly that for cancer patients, what they pursue is to extend the length of life and improve the quality of life. Cancer cure is a difficult problem in the world. This is the mentality that a qualified cancer patient should have. We cannot expect that one operation will solve it once and for all. Following the doctor's instructions and regular review are necessary processes. Cheng, however, the force majeure factor of the epidemic led to treatment interruption and recurrence of liver cancer. This had nothing to do with technology. He trusted the technology of Guangzhou St. Stamford Hospital. The minimally invasive technology here was far ahead of that in Laos, whether it was the integration of minimally invasive treatment concepts, advanced treatment equipment, or experienced doctors, so he chose to come back for treatment as soon as the epidemic was over. It turned out that Kaishun's choice was right, and he once again ushered in a new life for himself.
Attentive service and worry-free life

Kaishun and medical staff
"Here, you don't have to worry about language, food, etc. The hospital has taken every aspect into consideration, and translators and medical staff are always there." Facing the camera, Kaishun chatted easily about the medical staff and translator who had just completed a ward check and carefully checked various indicators of his body. He said that from the preparation for departure, the staff of the International Service Center helped to apply for passports and purchase air tickets. When arriving at the airport, there was a special car to pick up and drop off. There was no need to wait when arriving at the hospital, and you could check in immediately. The whole trip was smooth and without delay, and the medical staff and staff at the hospital were meticulous. He is very grateful to everyone here, who not only have superb medical skills, but also have a dedicated and professional spirit.
Guangzhou St. Stamford Hospital protects your health throughout your life
"This is the third time I have chosen to come here for treatment. I sincerely want to say to the majority of cancer patients, if you are looking for better and more reliable treatment methods, please come here." Guangzhou St. Stamford Hospital has accompanied thousands of international patients from Southeast Asia, Europe and the United States to successfully fight cancer, lighting a beacon for them on the road to anti-cancer. We not only have the world's cutting-edge minimally invasive treatment technology, but also have the highest quality transnational medical services, and will continue to protect the majority of international cancer patients.
